NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation

References

• Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol. 2020;15:493–518. doi:10.1146/annurev-pathmechdis-012419-032847
   PubMed Web of Science ®Google Scholar
• Sorriento D, Iaccarino G. Inflammation and cardiovascular diseases: the most recent findings. Int J Mol Sci. 2019;20(16):3879.
   PubMed Web of Science ®Google Scholar
• Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A. Resolvins: emerging players in autoimmune and inflammatory diseases. Clin Rev Allergy Immunol. 2020;58(1):82–91. doi:10.1007/s12016-019-08754-9
   PubMed Web of Science ®Google Scholar
• Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514–525. doi:10.1038/sj.jid.5700701
   PubMed Web of Science ®Google Scholar
• Dona I, Salas M, Perkins JR, et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Pharm Des. 2016;22(45):6784–6802. doi:10.2174/1381612822666160928142814
   PubMed Web of Science ®Google Scholar
• Freeman TL, Swartz TH. Targeting the NLRP3 inflammasome in severe COVID-19. Front Immunol. 2020;11:1518. doi:10.3389/fimmu.2020.01518
   PubMed Web of Science ®Google Scholar
• Liu D, Zeng X, Li X, et al. Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators. Biochem Pharmacol. 2020;175:113863. doi:10.1016/j.bcp.2020.113863
   PubMed Web of Science ®Google Scholar
• Yang Q, Liu R, Yu Q, Bi Y, Liu G. Metabolic regulation of inflammasomes in inflammation. Immunology. 2019;157(2):95–109.
   PubMed Web of Science ®Google Scholar
• Fusco R, Siracusa R, Genovese Tet al. Focus on the role of NLRP3 inflammasome in diseases. Int J Mol Sci. 2020;21(12):4223.
   PubMed Web of Science ®Google Scholar
• Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med. 2020;76:100889. doi:10.1016/j.mam.2020.100889
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276. doi:10.3389/fimmu.2019.00276
   PubMed Web of Science ®Google Scholar
• El-Saber Batiha G, Magdy beshbishy A, El-Mleeh A, Abdel-Daim MM, Prasad Devkota H. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae). Phytother Res. 2020;10(3):352.
   Google Scholar
• Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review. Phytother Res. 2018;32(12):2323–2339. doi:10.1002/ptr.6178
   PubMedGoogle Scholar
• Wang ZF, Liu J, Yang YA, Zhu HL. A review: the anti-inflammatory, anticancer and antibacterial properties of four kinds of licorice flavonoids isolated from licorice. Curr Med Chem. 2020;27(12):1997–2011. doi:10.2174/0929867325666181001104550
   PubMed Web of Science ®Google Scholar
• Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017;55(1):5–18. doi:10.1080/13880209.2016.1225775
   PubMed Web of Science ®Google Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:10.1038/nri.2016.58
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278–286. doi:10.1038/nature10759
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013–1022. doi:10.1016/j.cell.2014.04.007
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Nat Rev Immunol. 2016;13(2):148–159.
   Google Scholar
• Swanson KV, Deng M, Ting JP-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi:10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Lagarto JL, Nickdel MB, Kelly DJ, Price A, Nanchahal J. Autofluorescence lifetime reports cartilage damage in osteoarthritis. Sci Rep. 2020;10(1):2154. doi:10.1038/s41598-020-59219-5
   PubMed Web of Science ®Google Scholar
• Xia B, Di C, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95(6):495–505. doi:10.1007/s00223-014-9917-9
   PubMed Web of Science ®Google Scholar
• An S, Hu H, Li Y, Hu Y. Pyroptosis plays a role in osteoarthritis. Aging Dis. 2020;11(5):1146–1157. doi:10.14336/AD.2019.1127
   PubMed Web of Science ®Google Scholar
• McAllister MJ, Chemaly M, Eakin AJ, Gibson DS, McGilligan VE. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthritis Cartilage. 2018;26(5):612–619. doi:10.1016/j.joca.2018.02.901
   PubMed Web of Science ®Google Scholar
• Yan Z, Qi W, Zhan J, et al. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J Cell Mol Med. 2020;24(22):13046–13057. doi:10.1111/jcmm.15905
   PubMed Web of Science ®Google Scholar
• Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296–307. doi:10.1016/j.redox.2015.01.008
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Liu X, Wang T, Liu X, et al. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol. 2016;38:324–331. doi:10.1016/j.intimp.2016.06.009
   PubMed Web of Science ®Google Scholar
• Pan CW, Pan ZZ, Hu JJ, et al. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Eur J Pharmacol. 2016;770:85–91. doi:10.1016/j.ejphar.2015.12.006
   PubMed Web of Science ®Google Scholar
• Wang F, Gong S, Wang T, et al. Soyasaponin II protects against acute liver failure through diminishing YB-1 phosphorylation and Nlrp3-inflammasome priming in mice. Theranostics. 2020;10(6):2714–2726. doi:10.7150/thno.40128
   PubMed Web of Science ®Google Scholar
• Lv H, Yang H, Wang Z, et al. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A. Cell Death Dis. 2019;10(4):313. doi:10.1038/s41419-019-1543-z
   PubMed Web of Science ®Google Scholar
• Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 2014;134(11):2747–2756. doi:10.1038/jid.2014.221
   PubMed Web of Science ®Google Scholar
• Contassot E, French LE. New insights into acne pathogenesis: propionibacterium acnes activates the inflammasome. J Invest Dermatol. 2014;134(2):310–313. doi:10.1038/jid.2013.505
   PubMed Web of Science ®Google Scholar
• Kistowska M, Gehrke S, Jankovic D, et al. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J Invest Dermatol. 2014;134(3):677–685. doi:10.1038/jid.2013.438
   PubMed Web of Science ®Google Scholar
• Yang G, Lee HE, Yeon SH, et al. Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome. Phytother Res. 2018;32(12):2551–2559. doi:10.1002/ptr.6195
   PubMed Web of Science ®Google Scholar
• Wang J, Liao AM, Thakur K, Zhang JG, Huang J-H, Wei Z-J. Licochalcone B extracted from Glycyrrhiza uralensis Fisch induces apoptotic effects in human hepatoma cell HepG2. Journal of Agricultural and Food Chemistry. 2019;67(12):3341–3353. doi:10.1021/acs.jafc.9b00324
   PubMed Web of Science ®Google Scholar
• Li Q, Feng H, Wang H, et al. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction. EMBO Rep. 2021:e53499. doi:10.15252/embr.202153499
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Choi HK, Joosten LAB, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. doi:10.1038/s41572-019-0115-y
   PubMed Web of Science ®Google Scholar
• Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390. doi:10.1038/s41584-020-0441-1
   PubMed Web of Science ®Google Scholar
• Cui D, Liu S, Tang M, et al. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Phytomedicine. 2020;66:153111. doi:10.1016/j.phymed.2019.153111
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–2052. doi:10.1016/S0140-6736(16)00346-9
   PubMed Web of Science ®Google Scholar
• Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2016;31(6):890–896. doi:10.1093/ndt/gfv024
   PubMed Web of Science ®Google Scholar
• Hongyan L, Suling W, Weina Z, Yajie Z, Jie R. Antihyperuricemic effect of liquiritigenin in potassium oxonate-induced hyperuricemic rats. Biomed Pharmacother. 2016;84:1930–1936. doi:10.1016/j.biopha.2016.11.009
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124(3):139–152. doi:10.1042/CS20120198
   PubMed Web of Science ®Google Scholar
• Choi KM, Yoo HS. Amelioration of hyperglycemia-induced nephropathy by 3,3’-diindolylmethane in diabetic mice. Molecules. 2019;24(24):4474.
   PubMed Web of Science ®Google Scholar
• Zhu X, Shi J, Li H. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways. Biomed Pharmacother. 2018;106:976–982. doi:10.1016/j.biopha.2018.07.045
   PubMed Web of Science ®Google Scholar
• Fu Y, Chen J, Li YJ, Zheng YF, Li P. Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem. 2013;141(2):1063–1071. doi:10.1016/j.foodchem.2013.03.089
   PubMed Web of Science ®Google Scholar
• Ji S, Li Z, Song W, et al. Bioactive constituents of Glycyrrhiza uralensis (Licorice): discovery of the effective components of a traditional herbal medicine. J Nat Prod. 2016;79(2):281–292. doi:10.1021/acs.jnatprod.5b00877
   PubMed Web of Science ®Google Scholar
• Xu G, Fu S, Zhan X, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6(2). doi:10.1172/jci.insight.134601
   Web of Science ®Google Scholar
• Peng F, Du Q, Peng C, et al. A review: the pharmacology of isoliquiritigenin. Phytother Res. 2015;29(7):969–977. doi:10.1002/ptr.5348
   PubMed Web of Science ®Google Scholar
• Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B. 2015;5(4):310–315. doi:10.1016/j.apsb.2015.05.005
   PubMed Web of Science ®Google Scholar
• Zhao TT, Xu YQ, Hu HM, Gong HB, Zhu HL. Isoliquiritigenin (ISL) and its formulations: potential antitumor agents. Curr Med Chem. 2019;26(37):6786–6796. doi:10.2174/0929867325666181112091700
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu J, Huang S, et al. Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with kainic acid-induced seizures. Int Immunopharmacol. 2019;72:358–366. doi:10.1016/j.intimp.2019.04.028
   PubMed Web of Science ®Google Scholar
• d’Adesky ND, de Rivero Vaccari JP, Bhattacharya P, et al. Nicotine alters estrogen receptor-beta-regulated inflammasome activity and exacerbates ischemic brain damage in female rats. Int J Mol Sci. 2018;19(5):1330. doi:10.3390/ijms19051330
   PubMed Web of Science ®Google Scholar
• Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–731. doi:10.1016/S1474-4422(12)70104-7
   PubMed Web of Science ®Google Scholar
• Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593–601. doi:10.1038/nrneurol.2010.146
   PubMed Web of Science ®Google Scholar
• Zeng J, Chen Y, Ding R. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway. J Neuroinflammat. 2017;14(1):119. doi:10.1186/s12974-017-0895-5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li X, Grailer JJ, et al. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res. 2016;60(4):405–414. doi:10.1111/jpi.12322
   PubMed Web of Science ®Google Scholar
• Hosseinian N, Cho Y, Lockey RF, Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis. 2015;9(4):188–197. doi:10.1177/1753465815586335
   PubMed Web of Science ®Google Scholar
• Lee S, Suh GY, Ryter SW, Choi AM. Regulation and function of the nucleotide binding domain leucine-rich repeat-containing receptor, pyrin domain-containing-3 inflammasome in lung disease. Am J Respir Cell Mol Biol. 2016;54(2):151–160. doi:10.1165/rcmb.2015-0231TR
   PubMed Web of Science ®Google Scholar
• Liu Q, Lv H, Wen Z, Ci X, Peng L. Isoliquiritigenin activates nuclear factor erythroid-2 related factor 2 to suppress the NOD-like receptor protein 3 inflammasome and inhibits the NF-κB pathway in macrophages and in acute lung injury. Front Immunol. 2017;8:1518. doi:10.3389/fimmu.2017.01518
   PubMed Web of Science ®Google Scholar
• Nakamura S, Watanabe T, Tanigawa T, et al. Isoliquiritigenin ameliorates indomethacin-induced small intestinal damage by inhibiting NOD-like receptor family, pyrin domain-containing 3 inflammasome activation. Pharmacology. 2018;101(5–6):236–245. doi:10.1159/000486599
   PubMed Web of Science ®Google Scholar
• Persson GR. Periodontal complications with age. Periodontol 2000. 2018;78(1):185–194. doi:10.1111/prd.12227
   PubMed Web of Science ®Google Scholar
• El-Awady AR, Messer RL, Gamal AY, Sharawy MM, Wenger KH, Lapp CA. Periodontal ligament fibroblasts sustain destructive immune modulators of chronic periodontitis. J Periodontol. 2010;81(9):1324–1335. doi:10.1902/jop.2010.100054
   PubMed Web of Science ®Google Scholar
• Scheres N, Laine ML, Sipos PM, et al. Periodontal ligament and gingival fibroblasts from periodontitis patients are more active in interaction with Porphyromonas gingivalis. J Periodontal Res. 2011;46(4):407–416. doi:10.1111/j.1600-0765.2011.01353.x
   PubMed Web of Science ®Google Scholar
• Lian D, Dai L, Xie Z, et al. Periodontal ligament fibroblasts migration injury via ROS/TXNIP/Nlrp3 inflammasome pathway with Porphyromonas gingivalis lipopolysaccharide. Mol Immunol. 2018;103:209–219. doi:10.1016/j.molimm.2018.10.001
   PubMed Web of Science ®Google Scholar
• Gao Y, Lv X, Yang H, Peng L, Ci X. Isoliquiritigenin exerts antioxidative and anti-inflammatory effects via activating the KEAP-1/Nrf2 pathway and inhibiting the NF-κB and NLRP3 pathways in carrageenan-induced pleurisy. Food Funct. 2020;11(3):2522–2534. doi:10.1039/C9FO01984G
   PubMed Web of Science ®Google Scholar
• Honda H, Nagai Y, Matsunaga T, et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J Leukoc Biol. 2014;96(6):1087–1100. doi:10.1189/jlb.3A0114-005RR
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961–1970. doi:10.1016/S0140-6736(05)66665-2
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85(5):270–288. doi:10.1159/000447034
   PubMed Web of Science ®Google Scholar
• Li DX, Wang CN, Wang Y, et al. NLRP3 inflammasome-dependent pyroptosis and apoptosis in hippocampus neurons mediates depressive-like behavior in diabetic mice. Behav Brain Res. 2020;391:112684. doi:10.1016/j.bbr.2020.112684
   PubMed Web of Science ®Google Scholar
• Tian DD, Wang M, Liu A, et al. Antidepressant effect of paeoniflorin is through inhibiting pyroptosis CASP-11/GSDMD pathway. Mol Neurobiol. 2021;58(2):761–776. doi:10.1007/s12035-020-02144-5
   PubMed Web of Science ®Google Scholar
• Yang F, Zhu W, Cai X, et al. Minocycline alleviates NLRP3 inflammasome-dependent pyroptosis in monosodium glutamate-induced depressive rats. Biochem Biophys Res Commun. 2020;526(3):553–559. doi:10.1016/j.bbrc.2020.02.149
   PubMed Web of Science ®Google Scholar
• Li Y, Song W, Tong Y, et al. Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis. J Neuroinflammation. 2021;18(1):1. doi:10.1186/s12974-020-02040-8
   PubMed Web of Science ®Google Scholar
• Li X, Sun R, Liu R. Natural products in licorice for the therapy of liver diseases: progress and future opportunities. Pharmacol Res. 2019;144:210–226. doi:10.1016/j.phrs.2019.04.025
   PubMed Web of Science ®Google Scholar
• Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22(2):141–148. doi:10.1002/ptr.2295
   PubMed Web of Science ®Google Scholar
• Sun ZG, Zhao TT, Lu N, Yang YA, Zhu HL. Research progress of glycyrrhizic acid on antiviral activity. Mini Rev Med Chem. 2019;19(10):826–832. doi:10.2174/1389557519666190119111125
   PubMed Web of Science ®Google Scholar
• Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD/NASH. J Gastroenterol. 2018;53(3):362–376. doi:10.1007/s00535-017-1415-1
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi:10.1038/nrgastro.2017.109
   PubMed Web of Science ®Google Scholar
• Mridha AR, Wree A, Robertson AAB, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 2017;66(5):1037–1046. doi:10.1016/j.jhep.2017.01.022
   PubMed Web of Science ®Google Scholar
• Wan X, Xu C, Yu C, Li Y. Role of NLRP3 inflammasome in the progression of NAFLD to NASH. Can J Gastroenterol Hepatol. 2016;2016:6489012. doi:10.1155/2016/6489012
   PubMed Web of Science ®Google Scholar
• Knorr J, Wree A, Tacke F, Feldstein AE. The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis. 2020;40(3):298–306. doi:10.1055/s-0040-1708540
   PubMed Web of Science ®Google Scholar
• Yan T, Wang H, Cao L, et al. Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation. Drug Metab Dispos. 2018;46(9):1310–1319. doi:10.1124/dmd.118.082008
   PubMed Web of Science ®Google Scholar
• Liapis CD, Avgerinos ED, Kadoglou NP, Kakisis JD. What a vascular surgeon should know and do about atherosclerotic risk factors. J Vasc Surg. 2009;49(5):1348–1354. doi:10.1016/j.jvs.2008.12.046
   PubMed Web of Science ®Google Scholar
• Wang R, Wu W, Li W, et al. Activation of NLRP3 inflammasome promotes foam cell formation in vascular smooth muscle cells and atherogenesis via HMGB1. J Am Heart Assoc. 2018;7(19):e008596. doi:10.1161/JAHA.118.008596
   PubMed Web of Science ®Google Scholar
• Mounier R, Lobo D, Voulgaropoulos J, et al. The multistep road to ventilator-associated lung abscess: a retrospective study of S.aureus ventilator-associated pneumonia. PLoS One. 2017;12(12):e0189249. doi:10.1371/journal.pone.0189249
   PubMed Web of Science ®Google Scholar
• Yao L, Sun T. Glycyrrhizin administration ameliorates Streptococcus aureus-induced acute lung injury. Int Immunopharmacol. 2019;70:504–511. doi:10.1016/j.intimp.2019.02.046
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang T, Wang Y, et al. Blockade of extracellular high-mobility group box 1 attenuates inflammation-mediated damage and haze grade in mice with corneal wounds. Int Immunopharmacol. 2020;83:106468. doi:10.1016/j.intimp.2020.106468
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911. doi:10.1001/jama.2014.3192
   PubMed Web of Science ®Google Scholar
• Chi W, Chen H, Li F, Zhu Y, Yin W, Zhuo Y. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137. doi:10.1186/s12974-015-0360-2
   PubMed Web of Science ®Google Scholar
• Ahuja CS, Nori S, Tetreault L, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80(3s):S9–s22. doi:10.1093/neuros/nyw080
   PubMed Web of Science ®Google Scholar
• Moghaddam A, Child C, Bruckner T, Gerner HJ, Daniel V, Biglari B. Posttraumatic inflammation as a key to neuroregeneration after traumatic spinal cord injury. Int J Mol Sci. 2015;16(4):7900–7916. doi:10.3390/ijms16047900
   PubMed Web of Science ®Google Scholar
• Su XQ, Wang XY, Gong FT, et al. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury. Brain Res Bull. 2020;158:1–8. doi:10.1016/j.brainresbull.2020.02.009
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang Y, Cao Y, et al. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation. Biochem Biophys Res Commun. 2020;532(4):555–562. doi:10.1016/j.bbrc.2020.08.044
   PubMed Web of Science ®Google Scholar
• Hayes MT. Parkinson’s disease and parkinsonism. Am J Med. 2019;132(7):802–807. doi:10.1016/j.amjmed.2019.03.001
   PubMed Web of Science ®Google Scholar
• Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet. 2004;363(9423):1783–1793. doi:10.1016/S0140-6736(04)16305-8
   PubMed Web of Science ®Google Scholar
• Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK. Targeting the microglial NLRP3 inflammasome and its role in Parkinson’s disease. Mov Disord. 2020;35(1):20–33. doi:10.1002/mds.27874
   PubMed Web of Science ®Google Scholar
• Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E. Microglial inflammation and phagocytosis in Alzheimer’s disease: potential therapeutic targets. Br J Pharmacol. 2019;176(18):3515–3532. doi:10.1111/bph.14618
   PubMed Web of Science ®Google Scholar
• Yan YQ, Fang Y, Zheng R, Pu JL, Zhang BR. NLRP3 inflammasomes in Parkinson’s disease and their regulation by Parkin. Neuroscience. 2020;446:323–334. doi:10.1016/j.neuroscience.2020.08.004
   PubMed Web of Science ®Google Scholar
• Chen CM, Yen CY, Chen WL, et al. Pathomechanism characterization and potential therapeutics identification for Parkinson’s disease targeting neuroinflammation. Int J Mol Sci. 2021;22(3):1062.
   PubMed Web of Science ®Google Scholar
• Rheinheimer J, de Souza BM, Cardoso NS, Bauer AC, Crispim D. Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metabolism. 2017;74:1–9. doi:10.1016/j.metabol.2017.06.002
   PubMed Web of Science ®Google Scholar
• Tack CJ, Stienstra R, Joosten LA, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012;249(1):239–252. doi:10.1111/j.1600-065X.2012.01145.x
   PubMed Web of Science ®Google Scholar
• Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–188. doi:10.1038/nm.2279
   PubMed Web of Science ®Google Scholar
• Chen Y, Qian Q, Yu J. Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the IκB-α/NF-κB pathway and NLRP3 inflammasome. Biomed Pharmacother. 2019;115:108868. doi:10.1016/j.biopha.2019.108868
   PubMed Web of Science ®Google Scholar
• Yue SJ, Qin YF, Kang A, et al. Total flavonoids of Glycyrrhiza uralensis alleviates irinotecan-induced colitis via modification of gut microbiota and fecal metabolism. Front Immunol. 2021;12:628358. doi:10.3389/fimmu.2021.628358
   PubMed Web of Science ®Google Scholar
• Zou J, Li W, Wang G, et al. Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: involvement of alleviating intestinal microbiota dysbiosis. J Ethnopharmacol. 2021;267:113544. doi:10.1016/j.jep.2020.113544
   PubMed Web of Science ®Google Scholar
• Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(8):588–606. doi:10.1038/nrd.2018.97
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu A, Lv J, et al. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. Eur J Med Chem. 2020;185:111822. doi:10.1016/j.ejmech.2019.111822
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu G, Gao Y, et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin B. 2019;9(4):734–744. doi:10.1016/j.apsb.2019.02.003
   PubMed Web of Science ®Google Scholar
• Liu H, Zhan X, Xu G, et al. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacol Res. 2021;164:105384. doi:10.1016/j.phrs.2020.105384
   PubMed Web of Science ®Google Scholar
• Shi W, Xu G, Zhan X, et al. Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death Dis. 2020;11(4):252. doi:10.1038/s41419-020-2460-x
   PubMed Web of Science ®Google Scholar
• Qin N, Xu G, Wang Y, et al. Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity. Front Med. 2021;15(4):594–607. doi:10.1007/s11684-020-0809-2
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu G, Wang H, et al. Icariside II, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation. Acta Pharm Sin B. 2020;10(9):1619–1633. doi:10.1016/j.apsb.2020.03.006
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu G, Zhan X, et al. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice. Arch Toxicol. 2019;93(12):3585–3599. doi:10.1007/s00204-019-02606-3
   PubMed Web of Science ®Google Scholar